Semax 11mg

Semax 11mg — ACTH(4-10) Analog Research Peptide for Neurological Studies

Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4-10, with structural modifications that eliminate hormonal activity while preserving and enhancing neurological effects. Originally developed by Russian researchers, Semax has accumulated decades of published research documenting effects on cognitive function, neuroprotection, neurotrophic factor expression, and various neuropsychological parameters in animal models. The peptide is one of the most-studied members of the nootropic peptides research category.

BDNF and Neurotrophic Factor Research

One of Semax’s most-studied research mechanisms involves modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor (BDNF). Research has documented that Semax administration increases BDNF expression in brain tissue, supporting investigation of BDNF-mediated effects on neuronal survival, synaptic plasticity, and cognitive function. This neurotrophic mechanism distinguishes Semax from acute-acting neuromodulators.

Cognitive and Memory Research

Extensive research has documented Semax’s effects on cognitive function and memory in animal models. Studies have shown improvements in learning, memory consolidation, attention parameters, and cognitive performance in various behavioural tests. These effects involve multiple mechanisms including BDNF elevation, neurotransmitter system modulation, and direct effects on neuronal excitability in rodent neural tissue.

Neuroprotection Research

Semax has been extensively studied for neuroprotective effects in models of brain injury, stroke, and neurodegeneration. Research has documented protection against ischemic injury, reduced infarct volume in stroke models, and preservation of neuronal function under various toxic challenges. These neuroprotective effects involve multiple mechanisms including anti-inflammatory action, antioxidant effects, and neurotrophic support.

Neurotransmitter System Research

Research has characterized Semax’s effects on multiple neurotransmitter systems. Studies have documented modulation of dopamine, serotonin, noradrenaline, and acetylcholine systems in various brain regions. This broad neuropharmacological profile supports investigation of Semax effects across diverse research questions, from attention-related research to mood-related models.

Enkephalin and Opioid Research

An interesting aspect of Semax research involves effects on the enkephalin system. Research has documented that Semax influences enkephalin expression and breakdown, contributing to some of the peptide’s effects on stress responses, pain modulation, and mood-related behaviours in animal models, supporting use in behavioural neuroscience designs.

Comparison With Related Nootropic Peptides

Semax is frequently studied alongside other nootropic peptides such as Selank, sleep-regulating peptides like DSIP, and pineal-related peptides like Pinealon. Parallel investigations help characterize how melanocortin-derived nootropics compare with tuftsin- and pineal-derived peptides in matched behavioural research designs.

Quality, Storage, and Compliance

Each vial of Semax 11mg is manufactured to 99%+ HPLC-verified purity and supplied as a sterile lyophilized powder. Store unreconstituted vials at -20°C; reconstituted material should be refrigerated at 2–8°C. This Semax product is sold strictly for in-vitro laboratory research only — not for human consumption, diagnostic use, or any clinical application. Buyers must comply with all applicable provincial and federal regulations.